Centre Testing International Group Co. Ltd. Share Price
Stocks
300012
CNE100000GV8
Business Support Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.38 CNY | +0.56% |
|
+7.39% | +6.13% |
| 04-27 | Bioduro and Cti Biotechnology Form Strategic Partnership for Preclinical Drug Development | CI |
| 04-21 | Declaration of Voting Results by Centre Testing International | CI |
| Market Cap | 24.06B 3.56B 3.1B 2.88B 2.65B 5B 340B 5.07B 33.97B 13.33B 169B 13.37B 13.08B 568B | P/E 2026 * |
20.3x | P/E 2027 * | 17.6x |
|---|---|---|---|---|---|
| Enterprise Value | 22.36B 3.31B 2.88B 2.68B 2.46B 4.64B 316B 4.72B 31.57B 12.39B 157B 12.43B 12.16B 527B | EV / Sales 2026 * |
2.95x | EV / Sales 2027 * | 2.56x |
| Free-Float |
79.89% | Yield 2026 * |
1.32% | Yield 2027 * | 1.55% |
| 1 day | +0.56% | ||
| 1 week | +7.39% | ||
| 1 month | -4.39% | ||
| 3 months | -13.06% | ||
| 6 months | -7.41% | ||
| Current year | +6.13% |
| 1 week | 13.27 |  | 14.52 |
| 1 month | 12.85 | | 14.65 |
| Current year | 12.85 | | 17.97 |
| 1 year | 12.1 | | 17.97 |
| 3 years | 9.48 | | 21.1 |
| 5 years | 9.48 | | 29.86 |
| 10 years | 3.36 | | 35.3 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/12/22 | Sell | 230,000 | 0.0151% | |||
| 29/12/22 | Sell | Director | 380,000 | 0.0250% | ||
| 29/12/22 | Sell | Executive/Senior Manager | 175,000 | 0.0115% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.56% | +7.39% | +17.20% | -29.58% | 3.56B | |
| -0.66% | +2.57% | +15.68% | +13.43% | 23.39B | |
| -0.56% | +7.23% | +27.45% | - | 18.47B | |
| +11.37% | -2.59% | +23.86% | +5.30% | 2.43B | |
| -0.68% | +6.60% | -24.03% | -36.61% | 2.18B | |
| +0.69% | +2.52% | -33.73% | - | 1.62B | |
| +1.31% | +6.45% | -1.96% | +3.66% | 1.55B | |
| +1.27% | +4.40% | -12.20% | +2.01% | 1.34B | |
| +14.10% | +19.53% | +142.67% | +341.60% | 1.23B | |
| +3.28% | -15.83% | +37.45% | +70.00% | 1.21B | |
| Average | +3.07% | +1.85% | +19.24% | +46.23% | 5.7B | |
| Weighted average by Cap. | +0.50% | +2.27% | +19.09% | +17.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.58B 1.12B 976M 908M 834M 1.57B 107B 1.6B 10.7B 4.2B 53.33B 4.21B 4.12B 179B | 8.53B 1.26B 1.1B 1.02B 938M 1.77B 121B 1.8B 12.04B 4.73B 60.02B 4.74B 4.64B 201B |
| Net income | 1.19B 176M 153M 143M 131M 247M 16.83B 251M 1.68B 660M 8.38B 662M 648M 28.1B | 1.38B 204M 177M 165M 152M 286M 19.48B 291M 1.95B 764M 9.7B 766M 749M 32.51B |
| Net Debt | -1.7B -251M -218M -203M -187M -352M -23.98B -358M -2.4B -940M -11.94B -944M -923M -40.04B | -2.22B -329M -286M -266M -244M -461M -31.36B -468M -3.13B -1.23B -15.61B -1.23B -1.21B -52.35B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | CN¥14.38 | +0.56% | 29,698,799 |
| 30/07/26 | CN¥14.30 | +1.85% | 36,676,483 |
| 29/07/26 | CN¥14.04 | +4.70% | 46,500,290 |
| 28/07/26 | CN¥13.41 | -0.59% | 19,614,042 |
| 27/07/26 | CN¥13.49 | +0.75% | 22,061,299 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 300012 Stock
Select your edition
All financial news and data tailored to specific country editions
